Quantum-dot-based immunofluorescent imaging of HER2 and ER provides new insights into breast cancer heterogeneity
出版年份 2010 全文链接
标题
Quantum-dot-based immunofluorescent imaging of HER2 and ER provides new insights into breast cancer heterogeneity
作者
关键词
-
出版物
NANOTECHNOLOGY
Volume 21, Issue 9, Pages 095101
出版商
IOP Publishing
发表日期
2010-01-30
DOI
10.1088/0957-4484/21/9/095101
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
- (2009) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Quantum dots-based immunofluorescence technology for the quantitative determination of HER2 expression in breast cancer
- (2009) Chuang Chen et al. BIOMATERIALS
- Target-based therapies in breast cancer: current status and future perspectives
- (2009) Nicola Normanno et al. ENDOCRINE-RELATED CANCER
- The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies
- (2009) Jaclyn A. Freudenberg et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine
- (2009) J. S. Ross et al. ONCOLOGIST
- Quantitative Immunohistochemistry of Estrogen Receptor in Breast Cancer
- (2009) Mehrdad Nadji APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Hadamard transform spectral microscopy for single cell imaging using organic and quantum dotfluorescent probes
- (2008) Hao Xu et al. ANALYST
- The biocompatibility of quantum dot probes used for the targeted imaging of hepatocellular carcinoma metastasis
- (2008) Liang-Dong Chen et al. BIOMATERIALS
- Implications of applied research for prognosis and therapy of breast cancer
- (2008) M.F. Barginear et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance
- (2008) Grazia Arpino et al. ENDOCRINE REVIEWS
- Evolution of Knowledge Related to Breast Cancer Heterogeneity: A 25-Year Retrospective
- (2008) Bernard Fisher et al. JOURNAL OF CLINICAL ONCOLOGY
- A Decade of Tissue Microarrays: Progress in the Discovery and Validation of Cancer Biomarkers
- (2008) Robert L. Camp et al. JOURNAL OF CLINICAL ONCOLOGY
- Nanoparticle Fluorescence Based Technology for Biological Applications
- (2008) Wei Chen JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Quantum dots light up pathology
- (2008) E Tholouli et al. JOURNAL OF PATHOLOGY
- Current issues in ER and HER2 testing by IHC in breast cancer
- (2008) Allen M Gown MODERN PATHOLOGY
- Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives
- (2008) Hua Zhang et al. Nanomedicine
- Quantum dots versus organic dyes as fluorescent labels
- (2008) Ute Resch-Genger et al. NATURE METHODS
- Tissue Microarrays in Clinical Oncology
- (2008) David Voduc et al. SEMINARS IN RADIATION ONCOLOGY
- Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer
- (2008) Gabriella Mariani et al. Nature clinical practice. Oncology
- The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2
- (2008) Aleix Prat et al. Nature clinical practice. Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started